Prescribing Practices for Patients With Borderline Personality Disorder During Psychiatric Hospitalizations.

  • PubMed
  • May 4, 2025
  • 0 Comments

Prescribing Practices for Patients With Borderline Personality Disorder During Psychiatric Hospitalizations.

Autor: Romanowicz, Magdalena; Schak, Kathryn M.; Vande Voort, Jennifer L.; Leung, Jonathan G.; Larrabee, Beth R.; Palmer, Brian A.

Publication year: 2020

Journal of personality disorders

issn:1943-2763 0885-579X

doi: 10.1521/pedi_2019_33_405


Abstract:

This study aimed to understand prescribing practices during acute psychiatric hospitalization in a large cohort of patients (N = 569) with borderline personality disorder (BPD) at a tertiary care psychiatry unit from January 1, 2013, through January 1, 2015. The mean number of hospitalizations per patient was 1.5 (range, 1-7). The odds of being prescribed antidepressants, antipsychotics, mood stabilizers, hypnotics, or anxiolytics were higher at discharge than at admission. The rate of psychotropic prescriptions was also higher at discharge than at admission (incidence rate ratio, 1.9). This pattern was true for the combined psychotropic and nonpsychotropic (“medical”) prescriptions. Further guidelines are needed regarding optimal psychosocial, medical, and psychopharmacological care of patients with BPD during acute psychiatric hospitalizations.

Language: eng

Rights:

Pmid: 30742548

Tags: Humans; Hospitalization; acute care; polypharmacy; psychopharmacology; *Antipsychotic Agents/therapeutic use; *Borderline Personality Disorder/drug therapy/epidemiology; evidence-based treatment; Psychotropic Drugs/therapeutic use

Link: https://pubmed.ncbi.nlm.nih.gov/30742548/

  • Related Posts

    New Insights into Vaccination Strategies Against Pseudomonas aeruginosa in Cystic Fibrosis Patients

    Pseudomonas aeruginosa, a resilient and opportunistic bacterial pathogen, remains one of the primary causes of chronic lung infections in individuals with cystic fibrosis (CF). CF is a genetic disorder that…

    Auranofin Reduces Oral Steroid Requirement in Steroid-Dependent Asthma Treatment

    Researchers have identified auranofin, a gold-based compound previously used in the treatment of rheumatoid arthritis, as a promising adjunct therapy for patients with steroid-dependent asthma. The findings suggest that auranofin…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    West Johnston High and Triangle Math and Science Academy Compete in Brain Game Playoff

    • May 10, 2025
    West Johnston High and Triangle Math and Science Academy Compete in Brain Game Playoff

    New Study Reveals ‘Ice Piracy’ Phenomenon Accelerating Glacier Loss in West Antarctica

    • May 10, 2025
    New Study Reveals ‘Ice Piracy’ Phenomenon Accelerating Glacier Loss in West Antarctica

    New Study Suggests Certain Chemicals Disrupt Circadian Rhythm Like Caffeine

    • May 10, 2025
    New Study Suggests Certain Chemicals Disrupt Circadian Rhythm Like Caffeine

    Hospitalization Rates for Infants Under 8 Months Drop Significantly, Data Shows

    • May 10, 2025
    Hospitalization Rates for Infants Under 8 Months Drop Significantly, Data Shows

    Fleet Science Center Alters Anniversary Celebrations After Losing Grant Funding

    • May 10, 2025
    Fleet Science Center Alters Anniversary Celebrations After Losing Grant Funding

    How Microwaves Actually Work: A Scientific Breakdown

    • May 10, 2025
    How Microwaves Actually Work: A Scientific Breakdown